2-(4-Aminophenyl)benzothiazoles: novel agents with selective profiles of in vitro anti-tumour activity
1998

New Cancer Treatment Agents

publication Evidence: moderate

Author Information

Author(s): TD Bradshaw, S Wrigley, D-F Shi, RJ Schultz, KD Paull, MFG Stevens

Primary Institution: University of Nottingham

Hypothesis

Can 2-(4-aminophenyl)benzothiazoles selectively inhibit the growth of certain cancer cell lines?

Conclusion

The study found that 2-(4-aminophenyl)benzothiazoles exhibit selective and potent anti-tumor activity against specific breast cancer cell lines.

Supporting Evidence

  • 2-(4-aminophenyl)benzothiazoles showed unique profiles of growth inhibition.
  • IC50 values were significantly lower in sensitive breast cancer cell lines compared to prostate cancer cell lines.
  • Resistance to CJM 126 was observed in some MCF-7 cell lines after prolonged exposure.

Takeaway

Scientists discovered new compounds that can stop cancer cells from growing, especially in breast cancer, but they work differently than traditional treatments.

Methodology

The study involved in vitro assays to test the growth-inhibitory effects of various benzothiazole compounds on different cancer cell lines.

Limitations

The study primarily focused on in vitro results, which may not fully translate to in vivo effectiveness.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication